Annovis Bio (ANVS) Earnings Date & Reports

A.I. Advisor

published Earnings

ANVS is expected to report earnings to rise 4.57% to -46 cents per share on November 06

Q3'24

Est.

$-0.46

Q2'24

Beat

by $0.19

Q1'24

Beat

by $0.10

Q4'23

Missed

by $0.83

Q3'23

Missed

by $0.54

The last earnings report on August 15 showed earnings per share of -43 cents, beating the estimate of -62 cents. With 111.99K shares outstanding, the current market capitalization sits at 105.74M.

View a ticker or compare two or three

Compare

ANVS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For ANVS
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for ANVS (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a developer of drugs for Alzheimer's and Parkinson's diseases and other neurodegenerative disorders

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

101 Lindenwood Drive

Phone

+1 484 875-3192

Employees

Web

https://www.annovisbio.com